Founded in 2015, by Brad Pitts and Brandon Biles, Synergy’s mission is to ethically serve the healthcare sector and give healthcare providers quality service and accurate results. Synergy Laboratories is a full-service, diagnostic laboratory that performs clinical, toxicology and genetic testing. In a short period of time, Sure Med Compliance has made a big impact on prescribing habits in the Southeast United States and become the market leader in opioid prescribing compliance.
This is achieved through training, chart auditing, software integration and providing physicians with a written diversion control plan. Sure Med Compliance has a vision of ending the opioid epidemic through greater prescribing compliance. The two Mobile, Alabama based companies are planning more strategic partnerships across different industries and have begun developing new software to help manage patients on other controlled substances as well as patients being treated for addiction. In Synergy, we have found a partner whose technology will enhance our reporting and screening tools and the fact that they share so many of our core beliefs is icing on the cake.” He said, “We knew partnering with a diagnostic laboratory was necessary for building a solution that could start turning the tide of the opioid epidemic.
John Bowman, Sure Med Compliance’s Chief Executive Officer, echoed Pitts’ comments, and highlighted the common vision that both companies have for this partnership. He added, “Laboratory results often provide the first sign of substance misuse and deploying this technology will allow physicians to make more informed prescribing decisions.”
As a laboratory with a conscience, we believe we have a moral obligation to do everything in our power to provide physicians with every advantage when deciding if opioids are the preferred treatment option,” said Brad Pitts, Synergy’s Chief Executive Officer. “The opioid epidemic is affecting thousands of families in Alabama, and has ruined too many lives. As a result of the two companies’ partnership, diagnostic results such as urine drug screens can now be reported to the same dashboard that warns a provider of patient red flags found through the Sure Med Compliance patient evaluations. MOBILE, AL, Janu(BusinessWire) Sure Med Compliance® (SMC) and Synergy Laboratories (Synergy) are providing physicians a new weapon in the critical fight to combat the opioid epidemic. Results from Synergy Laboratories’ Diagnostic Tests to be Integrated into Sure Med Compliance’s Reporting and Screening Tools
0 kommentar(er)
